Cellular Dynamics International

About

Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.

Madison,Wisconsin,United States
51 - 100
http://www.cellulardynamics.com

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $40.60M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2004
Number Of Employee: 51 - 100
Operating Status: Active
Stock Symbol: nasdaq:ICEL
Legal Name: Cellular Dynamics International, Inc.
Also Known As: iPS Cells

Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$175.64M

Cellular Dynamics International has raised a total of $175.64M in funding over 2 rounds. Their latest funding was raised on Jul 25, 2013 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 25, 2013	IPO	$46M	—	—	—	Detail
Jul 3, 2013	Debt Financing	$20M	—	—	—	Detail
Nov 6, 2012	Series C	$21.04M	2	Tactics II Investments Rose Ventures	—	Detail
Apr 7, 2011	Series B	$30M	1	Tactics II Stem Cell Ventures	—	Detail
Apr 27, 2010	Series B	$40.60M	3	Tactics II Stem Cell Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

6

Cellular Dynamics International is funded by 6 investors. Tactics II Investments and Rose Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Tactics II Investments	Yes	Series C
Rose Ventures	Yes	Series C
Tactics II Stem Cell Ventures	Yes	Series B
Sixth Floor Investors	—	Series B
Equity Group Investments	—	Series B
Wisconsin Alumni Research Foundation	—	Series A